Metrion Biosciences Welcomes New CEO Lee Patterson

Metrion Biosciences, a leader in ion channel screening and preclinical contract research, has appointed Lee Patterson as its new CEO, effective December 2, 2024. With extensive experience in life sciences and contract research organizations, Patterson is set to drive the company's ambitious growth strategy.

Under his leadership, Metrion aims to enhance its specialist services and strengthen its global presence. This transition comes as Dr. Andrew S. steps down after five impactful years as CEO, marking a new chapter for the company’s strategic direction and innovation in the field.